IL10 and steatosis: The exogenous IL-10 supplementation (BD+IL-10+LT) increased IL-10 in non-steatotic and steatotic liver grafts (Figure 4); however, it did not abrogate the rise in parameters, indicating hepatic damage and inflammation in grafts obtained from DBDs in the absence of steatosis compared with the results of the BD+LT group (Figures 4, 5).